Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1200 participants.
Also called NCT04111419
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,200 participants
- Registry
-
NCT04111419
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04111419. Randomized; no masking; primary purpose treatment. Start 2020-07-01 (actual); primary completion 2026-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Condition
- Hypertension
- Intervention (Drug)
- Amlodipine/Atorvastatin 5 Mg-20 Mg ORAL TABLET
- Intervention (Drug)
- Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET
- Intervention (Drug)
- Allisartan Isoproxil
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct04111419- Content hash
659eef0c17f39f6fdad1424efe925bdf8ebbec0f1033c79c0a5797f86e66c772